Clinical trial
Phase II trial of palliative Epirubicin, Oxaliplatin & Capecitabine (EOX) Chemotherapy combined with omega-3 fish oil infusion (omegaven) in patients with oesophago-gastric carcinoma
To see whether adding intravenous ?-3 FA emulsion to standard palliative chemotherapy (EOX) improves quality of life and/or prognosis, in patients with incurable gastric or oesophageal carcinoma.
Category | Value |
---|---|
Study start date | 2012-01-05 |